STIMIT-I: Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Completed
CT.gov ID
NCT04946110
Collaborator
Stimit AG (Industry)
5
1
1
16
9.5

Study Details

Study Description

Brief Summary

Ventilator-induced diaphragmatic dysfunction is a common issue in critically ill patients. Muscle stimulation has shown to have beneficial effects in muscle groups on the extremities. A non-invasive way to stimulate the diaphragm would be the electromagnetic stimulation but it is currently unclear if that is feasible.

In this proof-of-concept trial the primary aim is to show that it is possible to induce a diaphragmatic contraction leading to an inspiration with a sufficient tidal volume via an external electromagnetic stimulation of the phrenic nerve.

Condition or Disease Intervention/Treatment Phase
  • Device: Electromagnetic stimulation
N/A

Detailed Description

During the time of first spontaneous breathing trial 60% of mechanically ventilated patients present with diaphragmatic weakness or also know as ventilator-induced diaphragmatic dysfunction (VIDD). The damage to the diaphragm in terms of muscle atrophy has been shown as early as 12 hours after initiation of mechanical ventilation. Recently, a correlation between diaphragmatic atrophy and mortality could be established.

Induction of diaphragmatic contractions via stimulation of the phrenic nerve would be a possible method to prevent or treat VIDD. A possible modality would be the non-invasive electromagnetic stimulation but feasibility has not been established.

In this proof-of-concept trial the primary aim is to show that it is possible to induce a diaphragmatic contraction leading to an inspiration with a sufficient tidal volume via an external electromagnetic stimulation of the phrenic nerve.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Electromagnetic Stimulation of the Phrenic Nerve to Generate Contraction of the Diaphragm in Anesthetized and Intubated Patients - a Proof-of-concept Study
Actual Study Start Date :
Jul 13, 2021
Actual Primary Completion Date :
Jul 29, 2021
Actual Study Completion Date :
Jul 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Electromagnetic stimulation

Electromagnetic stimulation of the phrenic nerve.

Device: Electromagnetic stimulation
Electromagnetic stimulation of the phrenic nerve

Outcome Measures

Primary Outcome Measures

  1. Tidal volume generated by electromagentical stimulation of the phrenic nerve (ml) [Study duration (approximately 10 minutes)]

    Mean tidal volume of 10 consecutively stimulations of the phrenic nerve

Secondary Outcome Measures

  1. Tidal volume per breath [Study duration (approximately 10 minutes)]

    Tidal volume

  2. Max inspiratory flow after stimulation [Study duration (approximately 10 minutes)]

    The maximal air flow created in the duct following stimulation of the N. phrenicus (meter / second)

  3. Abdominal extension maximum [Study duration (approximately 10 minutes)]

    Extension of the abdomen measured via in abdominal belt

  4. Air pressure during each breath [Study duration (approximately 10 minutes)]

    Change in pressure in the duct from expiration to inspiration (mbar)

  5. Diaphragmatic thickening fraction [Study duration (approximately 10 minutes)]

    Diaphragmatic contractility measured by ultrasound after N. phrenicus stimulation

  6. Feedback/Stimulation locus relation [Study duration (approximately 10 minutes)]

    When the stimulation locus is changed according to protocol the change of the triggered breath is measured in % to the original location.

  7. Latency between stimulation and feedback [Study duration (approximately 10 minutes)]

    Time between start and end of the stimulation in seconds

  8. Intensity/Contractility relation [Study duration (approximately 10 minutes)]

    Correlation between the simulation intensity and the diaphragmatic contractility

  9. Time to find the optimal stimulation point of the N. phrenicus [Study duration (approximately 10 minutes)]

    Time between first successful N. phrenicus stimulation and identification of the optimal stimulation locus in seconds

  10. Distance between anatomical landmarks and optimal stimulation locus [Study duration (approximately 10 minutes)]

    Distance between anatomical landmarks and optimal stimulation locus

  11. Reproducibility of stimulation answer [Study duration (approximately 10 minutes)]

    Variation of stimulated tidal volumes and diaphragm contraction

  12. Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] [Study duration (approximately 10 minutes)]

    Adverse Events elicited by the electromagnetic stimulation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ≥ 18 years of age

  • American Society of Anaesthesiologists Classification I or II

Exclusion Criteria:
  • Chronic lung disease

  • Preexisting diaphragmatic weakness

  • Neurologic disease with known motor weakness

  • Paralysis of the phrenic nerve

  • Contraindication for any movement in the cervical vertebrae

  • Conditions that limit the movement of the diaphragm e.g. ascites, increased intraabdominal pressure, adipositas.

  • Inability to communicate in the official language

  • Infections, lesions or stricture in the neck area

  • Implanted cardiac devices e.g. pace maker, defibrillator, event recorder

  • Implanted medical pumps e.g. left ventricular assist device

  • Metal implants in the upper body

  • Preganancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Charité - Univiversitätsmedizin Berlin Berlin Germany 10117

Sponsors and Collaborators

  • Charite University, Berlin, Germany
  • Stimit AG

Investigators

  • Principal Investigator: Stefan J Schaller, Prof. Dr., Charité - Universitätsmedizin Berlin, Berlin, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stefan J Schaller, Deputy Clinical Director, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT04946110
Other Study ID Numbers:
  • STIMIT-I
First Posted:
Jun 30, 2021
Last Update Posted:
Oct 27, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stefan J Schaller, Deputy Clinical Director, Charite University, Berlin, Germany
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2021